Recently, we reported that the patterns of antibodies to Helicobacter pylori protein antigens in serum may be useful for screening patients at high risk for ulcers ( Serological tests and assays for the diagnosis of Helicobacter pylori infection are included among the noninvasive methods recommended by the European Helicobacter pylori Study Group (7). Evaluation of the humoral immune response to H. pylori antigens by immunoblotting is a valuable alternative and complement to the more routinely used enzyme-linked immunosorbent assay (ELISA) tests (8,13,14,19,25). Immunoblotting appears to be sometimes more sensitive and useful for detecting low-abundance antibodies and antibodies directed toward nonconformational epitopes of immunodominant antigens. By this method, we recently reported that several antigens of H. pylori are preferentially recognized by the serum antibodies of adult French patients with gastroduodenal ulcers (GDU) that had been infected by this gastric pathogen. We therefore postulated that the five antigens corresponding to this antibody pattern could be useful for differentiating patients at high risk of GDU from patients with nonulcer dyspepsias (NUD) (2). Under the conditions of an immunoblot assay, two proteins of this antigenic profile were identified as CagA (125 kDa) and VacA (87 kDa), while the three other proteins were assigned only as immunoreactive bands with approximate molecular masses of 54, 42, and 35 kDa (denoted, respectively, p54, p42, and p35). Knowledge of the exact primary structure of p54, p42, and p35 is thus an essential prerequisite for preparing and further analyzing the antigenic preparation designed for the development of a test predicting the clinical outcome of the H. pylori infection.Our initial aim was to purify the three unidentified antigens in order to determine their amino acid sequences. After optimizing the electrophoretic separation of these antigens, we differentiated three antigens within the zone of p54. This prompted us to reinvestigate all members of antigenic profile by an immunoblot assay by using panels of sera from H. pyloripositive patients with GDU and NUD, as well as with the control sera of H. pylori-negative healthy volunteers.
MATERIALS AND METHODSPatients and patient sera. A total of 115 individual sera were collected in the university hospitals of Poitiers (southwest), Nancy (east), and Brest (northwest). These cities represent three geographical locations in France situated at a distance of more than 700 km from one another. Eighty-five sera were obtained from patients attending the departments of hepato-gastroenterology from 1995 to 2000. All patients underwent upper gastroduodenal endoscopy with multiple antral and fundic biopsies that were processed for histology. These subjects had received neither antimicrobial nor antiacid therapies during the previous 3 months. As determined by in-house ELISA (29), all patients were seropositive for H. pylori. Of the 85 patients, 55 (43 males and 12 females) had GDU, and 30 (17 males and 13 females) ...